Finch Legal raised a $3.75M seed in April 2025 to build pre-litigation AI for plaintiff firms. It's early — promising thesis, narrow product surface, and the unit economics of a recently-funded startup. If you're evaluating Finch, here's the honest read on how it compares to a 23-tool plaintiff suite with published pricing and a year of production usage behind it.
| Dimension | Finch Legal | MedLegal AI |
|---|---|---|
| Stage | Seed stage (Apr 2025, $3.75M) | Shipping; 23 tools live since 2025; 13 users, 5 paid |
| Product surface | Pre-litigation intake + evaluation (narrow by design) | 23 tools: intake, records, demands, depos, discovery, experts, audit, damages |
| Pricing | Not public (expect pilot contracts) | $49–$499/mo flat, published |
| Practice area tuning | General plaintiff PI | 7 areas: med-mal, NH, PI, birth injury, wrongful death, product liability, workers' comp |
| Medical records depth | Not a product focus at this stage | Braden↔MDS cross-checks, F-Tag 686/689, med anomalies, chart-gaming detection |
| Live deposition analysis | Not offered | Courtroom AI — real-time impeachment flagging, $99/$299 add-on |
| Demand letters | Roadmap item | Shipping — demand letter generator with plaintiff patterns |
| HIPAA posture | Confirm with vendor | BAA before upload; no records used for training; deletion on request |
| Trial / onboarding | Pilot-contract based | 14-day trial, no card, self-serve |
| Data lock-in | Early-stage platform; format TBD | PDF-in / PDF-out — no platform lock-in |
| Firm-size fit | Design partner firms (usually mid-sized) | Solo through 50-attorney firms |
| Track record | Early (~1 year since funding) | ~1 year shipping; production usage across Courtroom AI + suite |
It's not unreasonable to pilot both. Finch on pre-litigation intake for a narrow cohort, MedLegal AI for the rest of the case lifecycle. The two don't overlap today. If Finch eventually expands product surface into records / depos / demand letters, that picture changes — but at $3.75M seed stage, they'll likely stay narrow for another 18-24 months.
Plaintiff firms have a long history of being early adopters for legaltech — and a long history of buying pilot contracts from startups that didn't ship. About half the pre-2024 AI legaltech companies that raised seeds are no longer operating under the same brand. Not a prediction about Finch specifically — a reminder that "funded" isn't the same as "shipping at scale," and pilot contracts without usage data can become sunk costs quickly.
If you're going to bet on an early-stage vendor, do it with a 90-day termination clause and a defined usage benchmark. That's how you get the upside of early pricing and design-partner influence without the downside of a 2-year commitment to a company that stalls.
Start 14-Day Free Trial See Pricing
Finch Legal raised a $3.75M seed round in April 2025 to build pre-litigation AI for personal-injury cases — the focus is intake-to-demand-letter automation. They're a young company (early-product, limited public pricing) competing against EvenUp in the PI demand-letter space. MedLegal AI overlaps on demand-letter generation but adds 21 other med-mal-specific tools (Daubert, expert research, PubMed lit review) that Finch doesn't have.
Finch Legal hasn't publicly listed pricing as of May 2026 — they're early-stage and likely in pilot deployments. Industry-comparable pre-litigation AI tools (EvenUp, Eve Legal) charge $89-$800 per case. MedLegal AI is $49-$499/mo flat with no per-case fees. For a plaintiff attorney evaluating Finch in a sales call, MedLegal AI is the public-pricing baseline to anchor against.
Depends on your case mix. If you're plaintiff PI with a steady demand-letter pipeline and want to evaluate the newest tools, Finch's seed-stage pricing may be aggressive — worth a demo. If you're plaintiff med-mal, MedLegal AI's specialty depth (Daubert, PubMed, Courtroom AI) isn't on Finch's roadmap as a focus area. The 14-day MedLegal AI trial costs nothing to find out.
Finch's positioning is plaintiff PI/auto, not med-mal specifically. They handle medical-record summarization for PI demand letters, but lack the specialty-tool depth (Daubert challenges, expert-witness research, settlement evaluation tuned to med-mal damages, live deposition transcription) that defines MedLegal AI. Med-mal cases require expert testimony — that's where MedLegal AI's PubMed integration and Daubert analysis become load-bearing.
Not natively. Most attorneys evaluating both run them in parallel for 30 days on a few test cases, then commit to whichever workflow produces stronger output. MedLegal AI accepts uploads from any source (PDF, DOCX, raw text), so case data isn't trapped in either tool. If you're comparing seed-stage Finch against established MedLegal AI, the trial-and-decide approach is the lowest-risk evaluation path.